About this trial
this study aims To evaluate the diagnostic performance of Ultrasound (US) in correlation with Dynamic Magnetic Resonance Imaging (MRI) for the assessment, characterization, and evaluation of non-mass breast lesions.
The study will investigate whether DCE-MRI improves lesions detected by characterization and diagnostic accuracy when interpreted according to the ACR BIRADS v 2025 and so may help optimize breast imaging evaluation and support clinical decision making
Eligibility criteria
Qualifiers
• Female patients of any age presenting with non-mass breast lesions detected on MRI or conventional imaging.
Patients who have both MRI and targeted Ultrasound examinations.
Disqualifiers
• Patients presenting with typical distinct "mass" lesions (3D space-occupying lesions) without any non-mass components.
Patients with absolute contraindications to MRI (e.g., cardiac pacemakers, severe claustrophobia, non-compatible metallic implants).
Patients with contraindications to intravenous Gadolinium contrast media (e.g., severe renal impairment/failure, pregnancy, known history of severe allergic reaction to gadolinium).
Trial design
Treatments tested in this trial
- multiparametric DCE- MRI and US for all patients